Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

Quetiapine Fumarate

Trial Locations (36)

Unknown

Research Site, Birmingham

Research Site, Scottsdale

Research Site, Cerritos

Research Site, Garden Grove

Research Site, San Diego

Research Site, Torrance

Research Site, Jacksonville

Research Site, Maitland

Research Site, Orlando

Research Site, Winter Park

Research Site, Boise

Research Site, Oak Brook

Research Site, Overbrook Terrace

Research Site, Shreveport

Research Site, Baltimore

Research Site, Clementon

Research Site, Moorestown

Research Site, Albuquerque

Research Site, Brooklyn

Research Site, New York

Research Site, Staten Island

Research Site, Raleigh

Research Site, Cincinnati

Research Site, Dayton

Research Site, Oklahoma City

Research Site, Portland

Research Site, Philadelphia

Research Site, Pittsburgh

Research Site, Charleston

Research Site, Memphis

Research Site, Austin

Research Site, Houston

Research Site, Salt Lake City

Research Site, Bellevue

Research Site, Kirkland

Research Site, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY